Search
for
Sort by
Research 211–240 of 1000+
- Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework
- The Modulation of Aromatase and Estrogen Receptor Alpha in Cultured Human Dermal Papilla Cells by Dexamethasone: A Novel Mechanism for Selective Action of Estrogen via Estrogen Receptor Beta?
- Androgen insufficiency in women: diagnostic and therapeutic implications
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Histological and Gene Expression Analysis of the Effects of Menopause Status and Hormone Therapy on the Vaginal Introitus and Labia Majora
- Adult female acne: Clinical and therapeutic particularities (Review)
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- Female pattern hair loss: therapeutic update
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Therapeutic Potential of Brassinosteroids in Biomedical and Clinical Research
- Redefining hormone resistance in prostate cancer
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- Evidence-based approach to cutaneous hyperandrogenism in women
- Idiopathic Hirsutism*
- Contraceptive use in acne
- Androgen excess: a hallmark of polycystic ovary syndrome
- Combined hormonal contraception and venous thromboembolism
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- An Approach to the Patient With Hirsutism
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities